GetTopicDetailResponse(id=b66c9939334, topicName=非小細(xì)胞肺腺癌, introduction=非小細(xì)胞肺腺癌, content=null, image=null, comments=0, allHits=742, url=https://h5.medsci.cn/topic?id=99393, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=74766, tagList=[TagDto(tagId=74766, tagName=非小細(xì)胞肺腺癌)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2247453, encodeId=1f62224e453af, content=<a href='/topic/show?id=b66c9939334' target=_blank style='color:#2F92EE;'>#非小細(xì)胞肺腺癌#</a> <a href='/topic/show?id=33eb11e10878' target=_blank style='color:#2F92EE;'>#奧希替尼耐藥#</a>, objectTitle=奧希替尼聯(lián)合化療沒有效果了，埃萬妥單抗聯(lián)合拉澤替尼讓58%的患者臨床獲益！, objectType=article, longId=859031, objectId=45d885903101, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230621/1687280590581_5579292.jpg, objectUrl=/article/show_article.do?id=45d885903101, replyNumber=0, likeNumber=35, createdTime=2025-01-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=45d885903101, moduleTitle=奧希替尼聯(lián)合化療沒有效果了，埃萬妥單抗聯(lián)合拉澤替尼讓58%的患者臨床獲益！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=45d885903101)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
